https://www.selleckchem.com/pr....oducts/pf-03084014-p
5%, P= .04). Patients 35 years old were more likely to have central tumors (55% vs. 33%, P= .02) and to have bone (38% vs. 19%, P= .007) and lung (39% vs. 24%, P= .03) metastases. Compared to older patients ( 40 years), young patients were more likely to be never smokers (65.0% vs. 14.7%, P .001) and to have advanced disease (88% vs. 66%, P .001). Young patients with NSCLC often present with nonspecific symptoms and have advanced disease at diagnosis, often mimicking other pathologies. Awareness of the cli